FDA approves AbbVie combo hepatitis C treatment

Friday, December 19, 2014 - 16:01 in Health & Medicine

WASHINGTON, D.C. (AP) -- Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie....

Read the whole article on AP Health

More from AP Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net